The American Journal of Surgical Pathology · 2022 · 22 citations · 12 references
MedicineEndocrinologyOncologyCancer GeneticsMolecular OncologyNeoplasiaBone PathologyBone TumorsMalignant NeoplasmsMalignant TumorsOncogenic Signaling PathwaysRas Family OncogenesBrown TumorsHotspot MutationsMapk Pathway MutationsOncogenic Ras MutationsRas Pathway ActivationRas Signaling ActivationRas Signaling PathwayRas-driven Tumorigenesis
Brown tumors are rare and generally self-limiting mass lesions of bone occurring in the context of hyperparathyroidism. Although commonly regarded as endocrine-driven tumor-like lesions, we detected pathogenic hotspot KRAS mutations in 10/16 brown tumors (62%) with similar frequencies found in cases affecting the peripheral and axial skeleton. Pathogenic mutations in other driver genes of the RAS-MAPK pathway were not identified. Our findings suggest brown tumors to represent true neoplasms driven by the activation of the RAS-MAPK signaling pathway. The frequent regression of brown tumors after normalization of hyperparathyroidism points to a second hit mediated by endocrine stimulation to be required for tumor development. Our findings underline the pathogenic relation of brown tumors to nonossifying fibroma and giant cell granuloma of the jaws which both appear histologically similar to brown tumors and are also driven by RAS-MAPK signaling pathway activation.
12
Ras in Cancer and Developmental Diseases
Alberto Fernández‐Medarde, Eugenio Santos · Genes & Cancer · 2011 · 914 citations · Full text
Cancer-Associated Mutations in Endometriosis without Cancer
Michael S. Anglesio, Nickolas Papadopoulos, A. Ayhan et al. · New England Journal of Medicine · 2017 · 623 citations · Full text
Medicine, Gynecology, Oncology +14